查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
美國生理食鹽水市場規模和預測、區域佔有率、趨勢和成長機會分析報告範圍：按類型、包裝類型、應用、給藥途徑和最終用戶
市場調查報告書
商品編碼
1424144

美國生理食鹽水市場規模和預測、區域佔有率、趨勢和成長機會分析報告範圍：按類型、包裝類型、應用、給藥途徑和最終用戶

US Physiological Saline Market Size and Forecasts, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Packaging Type, Application, Route of Administration, and End User
出版日期: | 出版商: The Insight Partners | 英文 132 Pages | 訂單完成後即時交付

價格

2022年生理食鹽水市場價值為24.12億美元，預計到2030年將達到39.10億美元；預計2022年至2030年CAGR為6.2%。嚴重疾病、液體電解質失衡的盛行率上升以及老年人口對液體電解質的需求激增是導致生理食鹽水市場規模不斷成長的因素之一。然而，快速等滲鹽水輸注的不利影響阻礙了生理食鹽水市場的成長。

生理食鹽水溶液由具有相同pH值的等滲鹽溶液組成。生理食鹽水溶液的例子是林格氏溶液，由氯化鈉(NaCl)、碳酸氫鈉和氯化鉀溶液組成。醫生建議在患者出現脫水、液體失衡和更多臨床異常的情況下使用生理解決方案。

市場機會

使用低成本鹽溶液快速運送樣品

一種更便宜且容易獲得的鹽溶液可以運輸測試樣本，從而能夠更有效、安全、長距離地將樣本運送到診斷實驗室。一種現成的鹽溶液，如“磷酸鹽緩衝鹽水”，一種醫院和臨床實驗室常見的簡單鹽溶液，被用作冠狀病毒污染標本的運輸介質；鹽水可使樣品保持穩定長達 18 小時。在 COVID-19 大流行期間，病毒運輸介質的短缺給將從 COVID-19 患者身上獲取的標本運輸到診斷和測試實驗室帶來了重大挑戰，導致對無菌鹽溶液的需求激增。因此，研究人員建議使用廉價且常見的鹽溶液（例如磷酸鹽緩衝鹽溶液）進行運輸。因此，人們對更便宜、更容易獲得的鹽溶液及其在運輸醫學標本中的使用的認知不斷提高，可能會在 2022-2030 年期間為美國生理鹽水市場提供機會。

細分分析

基於類型的見解

依類型分類，美國生理食鹽水市場分為生理食鹽水、高滲透壓鹽水、低滲透壓鹽水和平衡鹽水。生理食鹽水細分市場在 2022 年佔據最大的市場佔有率，預計該細分市場在 2022 年至 2030 年期間CAGR最高。生理食鹽水 (NS) 是一種無菌鹽溶液，用於短期補液，因為它有助於恢復體內的電解質/鹽水平。它是一種 0.9% 的氯化鈉溶液，旨在治療人們的脫水和電解質失衡。 NS 是臨床上常用的靜脈注射液的基石。它適用於兒童和成人患者群體。使用經美國食品藥物管理局 (FDA) 批准的 NS 溶液的主要適應症如下：

細胞外液補充治療脫水、低血容、出血、敗血症等。

存在體液流失的代謝性鹼中毒的治療

輕度鈉缺乏

此外，NS只能透過靜脈注射給藥，生理食鹽水管理需要評估患者的健康狀況。藥劑師需要監控靜脈輸液的實施情況，同時根據患者的臨床情況安裝和建議訂單，並就劑量和給藥方面向醫院護理部門提供適當的諮詢。

基於包裝類型的見解

美國生理食鹽水市場依包裝類型分為軟袋、塑膠瓶和玻璃瓶。塑膠瓶細分市場將在 2022 年佔據更大的市場佔有率，預計軟袋細分市場在預測期內的CAGR最高。注射用氯化鈉 (NaCl) USP 溶液是無菌且無熱原的。它們是注射用水 (WFI) 中含有不同濃度 NaCl 的腸胃外溶液，用於靜脈 (IV) 給藥。此外，軟性容器由特殊配方的聚氯乙烯製成。然而，與塑膠容器接觸的溶液可能會從塑膠中濾出極少量的某些化學成分。此外，生物測試證明可以有效支持塑膠容器材料的安全性。因此，在預測期內，塑膠瓶預計將佔生理食鹽水市場的最小佔有率。

基於應用程式的見解

依應用分類，美國生理食鹽水市場分為靜脈注射、眼科、傷口照護、內視鏡檢查、皮膚擦傷等。靜脈注射細分市場在 2022 年佔據更大的市場佔有率，預計該細分市場在預測期內複合CAGR最高。配製靜脈 (IV) 鹽水溶液以預防或治療脫水。所有年齡層的醫生都會為受傷、生病、脫水或接受手術的人開靜脈注射生理食鹽水。鹽水靜脈注射袋提供快速、有針對性的解決方案來補充液體和緩解症狀。

此外，無菌水和氯化鈉或鹽和生理食鹽水靜脈注射的組合有助於恢復患者的體液平衡和水合組織。當患者需要水合作用時，通常會在患者的血液中註入靜脈注射鹽水。它適合對特定藥物過敏或敏感的人。

多家公司正在生產與靜脈注射鹽水相關的創新產品；例如，Fresenius Kabi USA 提供“freeflex”和“freeflex+ IV 袋”。這些產品還提供防漏、無菌保護和防針刺傷功能。

基於管理的洞察之路

美國生理食鹽水市場依給藥途徑分為靜脈注射和局部注射。靜脈注射細分市場在 2022 年佔據更大的市場佔有率，預計該細分市場在預測期內複合CAGR最高。靜脈注射鹽水溶液是專門配製的液體，注射靜脈以預防和治療脫水。此外，這些靜脈輸液適用於所有患有疾病、受傷、脫水等的年齡層的人。靜脈注射生理食鹽水是一種簡單、安全、常見的手術，併發症風險較低。此外，液體復甦是治療急診患者的重要組成部分，生理食鹽水被認為是重症或受傷患者最廣泛使用的靜脈輸液。作為一種常見、簡單且安全的手術，透過靜脈注射途徑給藥的患者可能會很快感到緩解。

目錄

第 1 章：簡介 13

  • Insight Partners 研究報告指南。 13
  • 市場區隔. 14

第 2 章：執行摘要 16

第 3 章：研究方法 17

  • 覆蓋範圍。 19
  • 二次研究。 19
  • 初步研究。 20

第 4 章：美國生理食鹽水市場格局 21

  • 概述。 21
  • PEST 分析。 22
    • 美國 PEST 分析。 22
  • 供應鏈分析。 22

第 5 章：美國生理食鹽水市場 - 主要產業動態 25

  • 主要市場促進因素。 26
    • 嚴重疾病和液體電解質失衡的盛行率不斷上升。 26
  • 人口老化對液體電解質的需求激增。 26
  • 主要市場限制：27
    • 快速等滲鹽水輸注的不良反應。 27
  • 主要市場機會：27
    • 較便宜的鹽溶液可以提高速度和運輸 27
  • 未來的趨勢。 28
    • 醫院環境中的大規模鹽溶液需求。 28
  • 影響分析：29

第 6 章：美國生理食鹽水市場 - 市場分析 30

  • 美國生理食鹽水市場收入，2020 - 2030. 30

第 7 章：美國生理食鹽水市場 - 收入和 2030 年預測 - 按類型 32

  • 概述。 32
  • 美國生理食鹽水市場收入佔有率，按類型 2022 年和 2030 年 (%) 32
  • 生理食鹽水。 33
  • 高滲鹽水。 35
  • 低滲鹽水。 37
  • 平衡鹽溶液。 39

第 8 章：美國生理食鹽水市場 - 2030 年收入和預測 - 按包裝類型 41

  • 概述。 41
  • 2022 年及 2030 年美國生理食鹽水市場收入佔有率，依包裝類型分類 (%) 41
  • 軟性袋。 42
  • 塑膠瓶。 44
  • 玻璃瓶。 46

第 9 章：美國生理食鹽水市場 - 2030 年收入與預測 -按應用48

  • 概述。 48
  • 2022 年及 2030 年美國生理食鹽水市場收入佔有率，依應用分類 (%) 48
  • 靜脈。 49
  • 眼科。 51
  • 傷口護理。 53
  • 內視鏡檢查。 55
  • 皮膚磨損。 56
  • 其他。 57

第 10 章：美國生理食鹽水市場 - 收入和 2030 年預測 - 按給藥途徑 58

  • 概述。 58
  • 2022 年及 2030 年美國生理食鹽水市場收入佔有率，依給藥途徑分類 (%) 58
  • 靜脈。 59
  • 主題 60

第 11 章：美國生理食鹽水市場 - 收入和 2030 年預測 - 按最終用戶 62

  • 概述。 62
  • 2022 年及 2030 年美國生理食鹽水市場收入佔有率，依最終用戶分類 (%) 62
  • 醫院。 63
  • 專科診所。 64
  • 門診手術中心。 65
  • 家庭護理。 66
  • 其他。 67

第 12 章：公司簡介

  • Fresenius Kabi AG. 68
  • Merck KGaA. 71
  • AdipoGen Life Sciences Inc. 78
  • Enzo Life Sciences Inc. 83
  • ICU Medical Inc. 88
  • Grifols SA. 94
  • Geno Technology Inc. 101
  • B Braun Medical Inc. 107
  • Pfizer Inc. 113
  • Ward's Science. 119

第13章：附錄129

  • 關於我們。 129
  • 專業術語。 131
Product Code: TIPRE00032155

The physiological saline market was valued at US$ 2.412 billion in 2022 and is projected to reach US$ 3.910 billion by 2030; it is estimated to register a CAGR of 6.2% from 2022 to 2030. The rising prevalence of serious illnesses, fluid electrolyte disorders, and surging demand for fluid electrolytes in the elderly population are among the factors contributing to the growing physiological saline market size. However, the adverse effects of rapid isotonic saline infusion hinder the growth of the physiological saline market.

A physiological saline solution is composed of isotonic salt solutions with the same pH. An example of a physiological saline solution is Ringer's solution, composed of sodium chloride (NaCl), sodium bicarbonate, and potassium chloride solution. The physician recommends the physiological solution in case of dehydration, fluid imbalances, and many more clinical abnormalities among the patients.

Market Opportunity

Rapid Sample Transportation Using Low-Cost Saline Solutions

A less expensive and readily available saline solution can transport testing samples, enabling more effective, safe, long-distance transportation of samples to diagnostic labs. A readily available saline solution such as "Phosphate Buffered Saline," a simple salt solution commonly available in hospitals and clinical laboratories, was used as a transport medium for coronavirus-contaminated specimens; the saline could keep the samples stable for up to 18 hours. During the COVID-19 pandemic, a shortage of viral transport media posed a major challenge in transporting specimens obtained from COVID-19 patients to diagnostics and testing labs, resulting in an upsurge in demand for sterile saline solutions. As a result, researchers recommended using inexpensive and commonly available salt solutions, such as phosphate-buffered saline solutions, for transportation. Therefore, the rising awareness of less expensive and readily available saline solutions and their use in transporting medical specimens will likely provide opportunities to the US physiological saline market during 2022-2030.

Segmental Analysis

Type-Based Insights

By type, the US physiological saline market is segmented into normal saline, hypertonic saline, hypotonic saline, and balanced saline. The normal saline segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022-2030. Normal saline (NS) comprises a sterile salt solution used for short-term fluid replacement, as it helps restore electrolyte/salt levels in the body. It is a 0.9% sodium chloride solution intended to treat dehydration and electrolyte disturbances among people. NS is a cornerstone of intravenous solutions commonly used in clinical settings. It is suitable for both pediatric and adult patient populations. Primary indications for the use of NS solutions that are approved by the Food and Drug Administration (FDA) are as follows:

Extracellular fluid replacement to treat dehydration, hypovolemia, hemorrhage, sepsis, etc.

Treatment of metabolic alkalosis in the presence of fluid loss

Mild sodium depletion

Further, NS can only be administered through intravenous access, and normal saline management requires evaluating the patient's health status. Pharmacists need to monitor the implementation of IV fluids while installing and recommending orders based on the patient's clinical situation with proper counseling to the nursing department in the hospital regarding dosage and administration.

Packaging Type-Based Insights

The US physiological saline market, by packaging type, is segmented into flexible bags, plastic bottles, and glass bottles. The plastic bottles segment held a larger market share in 2022, and the flexible bag segment is anticipated to register the highest CAGR during the forecast period. Sodium chloride (NaCl) USP solutions for injections are sterile and nonpyrogenic. They are parenteral solutions containing various NaCl concentrations in water for injection (WFI) intended for intravenous (IV) administration. Further, the flexible container is fabricated from a specially formulated polyvinyl chloride. However, solutions coming in contact with plastic containers might leach out certain chemical components from the plastic in very small amounts. Further, biological testing proves effective in supporting the safety of plastic container materials. Therefore, the plastic bottles segment is expected to account for the smallest share of the physiological saline market during the forecast period.

Application-Based Insights

By application, the US physiological saline market is segmented as intravenous, ophthalmology, wound care, endoscopy, skin abrasion, and others. The intravenous segment held a larger market share in 2022, and the same segment is anticipated to register the highest CAGR during the forecast period. Intravenous (IV) saline solutions are formulated to prevent or treat dehydration. Physicians of all ages prescribe IV saline for people who are injured, sick, dehydrated, or undergoing surgery. Saline IV bags provide a rapid, targeted solution to replenish fluids and relieve symptoms.

Furthermore, a combination of sterile water and sodium chloride, or salt and normal saline IVs, helps restore fluid balance and hydrate tissues among patients. IV saline is commonly administered to patient's bloodstreams when they require hydration. It is suitable for people with allergies or sensitivities to specific medications.

Various companies are producing innovative products related to IV saline; for example, Fresenius Kabi USA offers "freeflex" and "freeflex+ IV bags." These products also provide leak prevention, sterility protection, and needle-stick prevention.

Route of Administration-Based Insights

The US physiological saline market, by route of administration, is bifurcated into intravenous and topical. The intravenous segment held a larger market share in 2022, and the same segment is anticipated to register the highest CAGR during the forecast period. IV saline solutions are specially formulated liquids that are injected into a vein to prevent and treat dehydration. Also, these IV fluids are utilized among people of all ages suffering from sickness, injury, dehydration, etc. The IV saline solution is a simple, safe, and common procedure with a low risk of complications. Also, fluid resuscitation is a vital component for managing acutely ill patients, and normal saline is considered the most widely used IV fluid for seriously ill or injured patients. Being a common, simple, and safe procedure, patients administered via the IV route may feel relief quickly.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the US physiological saline market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global US physiological saline market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth country market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction 13

  • 1.1 The Insight Partners Research Report Guidance. 13
  • 1.2 Market Segmentation. 14

2. Executive Summary 16

3. Research Methodology 17

  • 3.1 Coverage. 19
  • 3.2 Secondary Research. 19
  • 3.3 Primary Research. 20

4. US Physiological Saline Market Landscape 21

  • 4.1 Overview. 21
  • 4.2 PEST Analysis. 22
    • 4.2.1 US PEST Analysis. 22
  • 4.3 Supply Chain Analysis. 22

5. US Physiological Saline Market - Key Industry Dynamics 25

  • 5.1 Key Market Drivers. 26
    • 5.1.1 Rising Prevalence of Serious Illnesses and Fluid Electrolytes Disorders. 26
  • 5.2 Surging Demand for Fluid Electrolytes in Aging Population. 26
  • 5.3 Key Market Restraints: 27
    • 5.3.1 Adverse Effects of Rapid Isotonic Saline Infusion. 27
  • 5.4 Key Market Opportunities: 27
    • 5.4.1 Less Expensive Saline Solution Can Improve Speed and Transport 27
  • 5.5 Future Trends. 28
    • 5.5.1 Large-Scale Saline Solution Requirements in Hospital Settings. 28
  • 5.6 Impact Analysis: 29

6. US Physiological Saline Market - Market Analysis 30

  • 6.1 US Physiological Saline Market Revenue (US$ Mn), 2020 - 2030. 30

7. US Physiological Saline Market - Revenue and Forecast to 2030 - by Type 32

  • 7.1 Overview. 32
  • 7.2 US Physiological Saline Market Revenue Share, by Type 2022 & 2030 (%) 32
  • 7.3 Normal Saline. 33
    • 7.3.1 Overview. 33
    • 7.3.2 Normal Saline: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 33
  • 7.4 Hypertonic Saline. 35
    • 7.4.1 Overview. 35
    • 7.4.2 Hypertonic Saline: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 35
  • 7.5 Hypotonic Saline. 37
    • 7.5.1 Overview. 37
    • 7.5.2 Hypotonic Saline: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 37
  • 7.6 Balanced Saline Solution. 39
    • 7.6.1 Overview. 39
    • 7.6.2 Balanced Saline Solution: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 39

8. US Physiological Saline Market - Revenue and Forecast to 2030 - by Packaging Type 41

  • 8.1 Overview. 41
  • 8.2 US Physiological Saline Market Revenue Share, by Packaging Type 2022 & 2030 (%) 41
  • 8.3 Flexible Bags. 42
    • 8.3.1 Overview. 42
    • 8.3.2 Flexible Bags: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 42
  • 8.4 Plastic Bottles. 44
    • 8.4.1 Overview. 44
    • 8.4.2 Plastic Bottles: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 44
  • 8.5 Glass Bottles. 46
    • 8.5.1 Overview. 46
    • 8.5.2 Glass Bottles: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 46

9. US Physiological Saline Market - Revenue and Forecast to 2030 - by Application 48

  • 9.1 Overview. 48
  • 9.2 US Physiological Saline Market Revenue Share, by Application 2022 & 2030 (%) 48
  • 9.3 Intravenous. 49
    • 9.3.1 Overview. 49
    • 9.3.2 Intravenous: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 49
  • 9.4 Ophthalmology. 51
    • 9.4.1 Overview. 51
    • 9.4.2 Ophthalmology: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 51
  • 9.5 Wound Care. 53
    • 9.5.1 Overview. 53
    • 9.5.2 Wound Care: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 53
  • 9.6 Endoscopy. 55
    • 9.6.1 Overview. 55
    • 9.6.2 Endoscopy: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 55
  • 9.7 Skin Abrasion. 56
    • 9.7.1 Overview. 56
    • 9.7.2 Skin Abrasion: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 56
  • 9.8 Others. 57
    • 9.8.1 Overview. 57
    • 9.8.2 Others: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 57

10. US Physiological Saline Market - Revenue and Forecast to 2030 - by Route of Administration 58

  • 10.1 Overview. 58
  • 10.2 US Physiological Saline Market Revenue Share, by Route of Administration 2022 & 2030 (%) 58
  • 10.3 Intravenous. 59
    • 10.3.1 Overview. 59
    • 10.3.2 Intravenous: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 59
  • 10.4 Topical 60
    • 10.4.1 Overview. 60
    • 10.4.2 Topical: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 60

11. US Physiological Saline Market - Revenue and Forecast to 2030 - by End User 62

  • 11.1 Overview. 62
  • 11.2 US Physiological Saline Market Revenue Share, by End User 2022 & 2030 (%) 62
  • 11.3 Hospitals. 63
    • 11.3.1 Overview. 63
    • 11.3.2 Hospitals: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 63
  • 11.4 Specialty Clinics. 64
    • 11.4.1 Overview. 64
    • 11.4.2 Specialty Clinics: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 64
  • 11.5 Ambulatory Surgical Centers. 65
    • 11.5.1 Overview. 65
    • 11.5.2 Ambulatory Surgical Centers: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 65
  • 11.6 Homecare. 66
    • 11.6.1 Overview. 66
    • 11.6.2 Homecare: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 66
  • 11.7 Others. 67
    • 11.7.1 Overview. 67
    • 11.7.2 Others: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 67

12. Company Profiles 68

  • 12.1 Fresenius Kabi AG. 68
    • 12.1.1 Key Facts. 68
    • 12.1.2 Business Description. 68
    • 12.1.3 Products and Services. 69
    • 12.1.4 Financial Overview. 69
    • 12.1.5 SWOT Analysis. 70
    • 12.1.6 Key Developments. 70
  • 12.2 Merck KGaA. 71
    • 12.2.1 Key Facts. 71
    • 12.2.2 Business Description. 71
    • 12.2.3 Products and Services. 72
    • 12.2.4 Financial Overview. 74
    • 12.2.5 SWOT Analysis. 77
    • 12.2.6 Key Developments. 77
  • 12.3 AdipoGen Life Sciences Inc. 78
    • 12.3.1 Key Facts. 78
    • 12.3.2 Business Description. 78
    • 12.3.3 Products and Services. 79
    • 12.3.4 Financial Overview. 82
    • 12.3.5 SWOT Analysis. 82
    • 12.3.6 Key Developments. 82
  • 12.4 Enzo Life Sciences Inc. 83
    • 12.4.1 Key Facts. 83
    • 12.4.2 Business Description. 83
    • 12.4.3 Products and Services. 84
    • 12.4.4 Financial Overview. 86
    • 12.4.5 SWOT Analysis. 87
    • 12.4.6 Key Developments. 87
  • 12.5 ICU Medical Inc. 88
    • 12.5.1 Key Facts. 88
    • 12.5.2 Business Description. 88
    • 12.5.3 Products and Services. 89
    • 12.5.4 Financial Overview. 90
    • 12.5.5 SWOT Analysis. 92
    • 12.5.6 Key Developments. 93
  • 12.6 Grifols SA. 94
    • 12.6.1 Key Facts. 94
    • 12.6.2 Business Description. 94
    • 12.6.3 Products and Services. 95
    • 12.6.4 Financial Overview. 97
    • 12.6.5 SWOT Analysis. 99
    • 12.6.6 Key Developments. 100
  • 12.7 Geno Technology Inc. 101
    • 12.7.1 Key Facts. 101
    • 12.7.2 Business Description. 101
    • 12.7.3 Products and Services. 102
    • 12.7.4 Financial Overview. 105
    • 12.7.5 SWOT Analysis. 105
    • 12.7.6 Key Developments. 106
  • 12.8 B Braun Medical Inc. 107
    • 12.8.1 Key Facts. 107
    • 12.8.2 Business Description. 107
    • 12.8.3 Products and Services. 108
    • 12.8.4 Financial Overview. 111
    • 12.8.5 SWOT Analysis. 111
    • 12.8.6 Key Developments. 112
  • 12.9 Pfizer Inc. 113
    • 12.9.1 Key Facts. 113
    • 12.9.2 Business Description. 113
    • 12.9.3 Products and Services. 114
    • 12.9.4 Financial Overview. 115
    • 12.9.5 SWOT Analysis. 117
    • 12.9.6 Key Developments. 118
  • 12.10 Ward's Science. 119
    • 12.10.1 Key Facts. 119
    • 12.10.2 Business Description. 119
    • 12.10.3 Products and Services. 120
    • 12.10.4 Financial Overview. 127
    • 12.10.5 SWOT Analysis. 128
    • 12.10.6 Key Developments. 128

13. Appendix 129

  • 13.1 About Us. 129
  • 13.2 Glossary of Terms. 131

List Of Tables

  • Table 1. US Physiological Saline Market Segmentation. 14
  • Table 2. Normal Saline 2020-2030 (US$ Mn) 34
  • Table 3. Normal Saline 2020-2030 (US$ Mn) 36
  • Table 4. Hypotonic Saline 2020-2030 (US$ Mn) 38
  • Table 5. Balanced Saline Solution (BSS) 2020-2030 (US$ Mn) 40
  • Table 6. Flexible Bags 2020-2030 (US$ Mn) 43
  • Table 7. Plastic Bottles 2020-2030 (US$ Mn) 45
  • Table 8. Glass Bottles 2020-2030 (US$ Mn) 47
  • Table 9. Topical 2020-2030 (US$ Mn) 61
  • Table 10. Glossary of Terms, US Physiological Saline Market 131

List Of Figures

  • Figure 1. US Physiological Saline Market Segmentation, By Country. 15
  • Figure 2. Key Insights. 16
  • Figure 3. US - PEST Analysis. 22
  • Figure 4. US Physiological Saline Market - Key Industry Dynamics. 25
  • Figure 5. Impact Analysis of Drivers and Restraints. 29
  • Figure 6. US Physiological Saline Market Revenue (US$ Mn), 2020 - 2030. 31
  • Figure 7. US Physiological Saline Market Revenue Share, by Type 2022 & 2030 (%) 32
  • Figure 8. Normal Saline: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 34
  • Figure 9. Hypertonic Saline: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 36
  • Figure 10. Hypertonic Saline: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 38
  • Figure 11. Balanced Saline Solution: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 40
  • Figure 12. US Physiological Saline Market Revenue Share, by Packaging Type 2022 & 2030 (%) 41
  • Figure 13. Flexible Bags: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 43
  • Figure 14. Plastic Bottles: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 45
  • Figure 15. Glass Bottles: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 47
  • Figure 16. US Physiological Saline Market Revenue Share, by Application 2022 & 2030 (%) 48
  • Figure 17. Intravenous: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 50
  • Figure 18. Ophthalmology: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 52
  • Figure 19. Wound Care: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 54
  • Figure 20. Endoscopy: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 55
  • Figure 21. Skin Abrasion: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 56
  • Figure 22. Others: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 57
  • Figure 23. US Physiological Saline Market Revenue Share, by Route of Administration 2022 & 2030 (%) 58
  • Figure 24. Intravenous: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 59
  • Figure 25. Topical: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 60
  • Figure 26. US Physiological Saline Market Revenue Share, by End User 2022 & 2030 (%) 62
  • Figure 27. Hospitals: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 63
  • Figure 28. Specialty Clinics: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 64
  • Figure 29. Ambulatory Surgical Centers: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 65
  • Figure 30. Homecare: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 66
  • Figure 31. Others: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 67